Identifying Risk Factors for Osteonecrosis in Patients With Systemic Lupus Erythematosus – Rheumatology Advisor

Corticosteroid treatment is a major predictor of osteonecrosis in patients with systemic lupus erythematosus (SLE); a daily dose of 20 to 39 mg of prednisone for more than 1 month or prednisone greater than 40 mg per month is associated with an increased risk for osteonecrosis, according to study results published in Arthritis Care & Research.
Osteonecrosis, most commonly seen in the femoral head, is a serious complication of SLE. The objective of the current study was to identify predictors of…

Click here to view the original article.